Wyoming Medicaid Becomes First State to Cover Cognoa’s Canvas Dx, Expanding Access to Early Autism DiagnosisRead More
Cognoa Appoints Michael Butler as Board Executive Chair to Further Propel Access to First FDA Authorized Diagnostic for AutismRead More
New Study Sponsored by Cognoa Exposes Alarming Wait Times and Persistent Inequities Obstructing Early Autism Diagnosis and Early InterventionsRead More
Cognoa and Health Transformation Alliance Partner to Provide Access to Child Health Solution Canvas Dx for Self-Insured EmployersRead More
Cognoa Appoints Pediatric Neurologist and AI in Healthcare Pioneer Dr. Sharief Taraman as CEO to Spearhead the Next Stage of the Company’s GrowthRead More
Cognoa Announces Poster Presentations at the 2022 American Academy of Pediatrics (AAP) National Conference and ExhibitionRead More
ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas Dx Read More
Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for AutismRead More
Cognoa to Present and Exhibit at the 2022 American Academy of Neurology (AAN) Annual MeetingRead More
